Heinz Albert Duerk - St. Barbara-Klinik Hamm

基本信息

浏览量：4

职业迁徙

个人简介

Heinz Albert Duerk currently works at the Hematology and Medical Oncology, St. Barbara-Klinik Hamm. Heinz does research in Multiple Myeloma, Non-Hodgkin-Lymphoma and Leukemia.

研究兴趣

论文共 8 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P554: RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED PHASE 2 STUDY OF HYPOMETHYLATING AGENTS WITH OR WITHOUT ELTROMBOPAG IN ELDERLY AML PATIENTS (DELTA)

HemaSphereno. S3 (2023)

引用0浏览0引用

Sorafenib or Placebo in Patients with Newly Diagnosed Acute Myeloid Leukaemia: Long-Term Follow-Up of the Randomized Controlled SORAML Trial

Leukemia（2021）

引用44浏览0WOSNATURE引用

Donor-cell Leukemia with Novel Genetic Features 2 Years after Sex-Mismatched T Cell-Depleted Haploidentical Stem Cell Transplantation

Verena Luber,Mathias Lutz,Christian Thiede,Claudia Haferlach,Heinz Albert Dürk,Hermann Einsele,Götz Ulrich Grigoleit,Stephan Mielke

Annals of Hematology（2020）

引用1浏览0WOS引用

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Blood（2017）

引用24浏览0引用

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Bloodno. 22 (2016): 185-185

引用10浏览0引用

Maintenance Therapy for Multiple Myeloma with Particular Emphasis on Thalidomide

Heinz Albert Duerk

Oncology Research and Treatment（2006）

引用8浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn